Drugs / GSK134612A
last change Mar 2006 re-read 2 minutes ago

GSK134612A

Vaccine

Developed for
meningococcal infection
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00196976 Mar 2005 → Mar 2006 meningococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK134612A “one dose of formulation 1 (Form1) of the GSK134612A conjugate vaccine, intramuscularly into the left arm's deltoid region” NCT00196976
Modality Vaccine “GSK134612A conjugate vaccineNCT00196976
Route Intramuscular intramuscularly into the left arm's deltoid region” NCT00196976